Sarah Weller1, Nicolas H Hart2, Kate A Bolam3, Sami Mansfield4, Daniel Santa Mina5, Kerri M Winters-Stone6, Anna Campbell7, Friederike Rosenberger8, Joachim Wiskemann9, Morten Quist10, Prue Cormie11, Jennifer Goulart12, Kristin L Campbell13. 1. Provincial Programs, BC Cancer, 750 West Broadway, Vancouver, BC, V5Z 1H5, Canada. Electronic address: https://twitter.com/_sarahweller. 2. Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, 191 Ipswich Rd, Woolloongabba, QLD, 4102, Australia; Exercise Medicine Research Institute, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia; Institute for Health Research, University of Notre Dame Australia, 23 High Street, Freemantle, WA, 6160, Australia. Electronic address: https://twitter.com/DrNicolasHart. 3. Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Fack 23400, SE-141 83 Huddinge, Stockholm, Sweden. Electronic address: https://twitter.com/katebolam. 4. Cancer Wellness for Life, 8022 Reeder Street, Lenexa, KS, 66214, USA. Electronic address: https://twitter.com/bewellwithsami. 5. Faculty of Kinesiology and Physical Education, University of Toronto, 27 King's College Cir, Toronto, Ontario, ON M5S, Canada. Electronic address: https://twitter.com/DR_SantaMina. 6. Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA. Electronic address: https://twitter.com/winters_stone. 7. Department of Sport, Exercise and Health & Science, School of Applied Sciences, Edinburgh Napier University, Sighthill Court, Edinburgh, EH11 4BN, UK. Electronic address: https://twitter.com/CanRehab. 8. Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, Heidelberg, 69120, Germany. 9. Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, Heidelberg, 69120, Germany. Electronic address: https://twitter.com/exoncolgermany. 10. The University Hospitals Centre for Health Research, Rigshospitalet, Blegdamsvej 9, 2100, København, Denmark. Electronic address: https://twitter.com/QuistMorten. 11. Mary MacKillop Institute for Health Research, Australian Catholic University, 5/215 Spring Street, Melbourne, VIC, 3000, Australia. Electronic address: https://twitter.com/PrueCormie. 12. Department of Radiation Oncology, BC Cancer, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada. 13. Department of Physical Therapy, 212-2177 Wesbrook Mall, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. Electronic address: kristin.campbell@ubc.ca.
Abstract
BACKGROUND: Exercise has the potential to improve physical function and quality of life in individuals with bone metastases but is often avoided due to safety concerns. This systematic review summarizes the safety, feasibility and efficacy of exercise in controlled trials that include individuals with bone metastases. METHODS: MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL databases were searched up to July 16, 2020. RESULTS: A total of 17 trials were included incorporating aerobic exercise, resistance exercise or soccer interventions. Few (n = 4, 0.5%) serious adverse events were attributed to exercise participation, with none related to bone metastases. Mixed efficacy results were found, with exercise eliciting positive changes or no change. The majority of trials included an element of supervised exercise instruction (n = 16, 94%) and were delivered by qualified exercise professionals (n = 13, 76%). CONCLUSIONS: Exercise appears safe and feasible for individuals with bone metastases when it includes an element of supervised exercise instruction.
BACKGROUND: Exercise has the potential to improve physical function and quality of life in individuals with bone metastases but is often avoided due to safety concerns. This systematic review summarizes the safety, feasibility and efficacy of exercise in controlled trials that include individuals with bone metastases. METHODS: MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL databases were searched up to July 16, 2020. RESULTS: A total of 17 trials were included incorporating aerobic exercise, resistance exercise or soccer interventions. Few (n = 4, 0.5%) serious adverse events were attributed to exercise participation, with none related to bone metastases. Mixed efficacy results were found, with exercise eliciting positive changes or no change. The majority of trials included an element of supervised exercise instruction (n = 16, 94%) and were delivered by qualified exercise professionals (n = 13, 76%). CONCLUSIONS: Exercise appears safe and feasible for individuals with bone metastases when it includes an element of supervised exercise instruction.
Authors: Nicolas H Hart; Dagmara M Poprawski; Fred Ashbury; Margaret I Fitch; Raymond J Chan; Robert U Newton; Kristin L Campbell Journal: Support Care Cancer Date: 2022-09 Impact factor: 3.359
Authors: Oscar Barnes; Rebekah L Wilson; Paola Gonzalo-Encabo; Dong-Woo Kang; Cami N Christopher; Thomas Bentley; Christina M Dieli-Conwright Journal: Nutrients Date: 2022-05-18 Impact factor: 6.706
Authors: Holly E L Evans; Daniel A Galvão; Cynthia C Forbes; Danielle Girard; Corneel Vandelanotte; Robert U Newton; Andrew D Vincent; Gary Wittert; Ganessan Kichenadasse; Suzanne Chambers; Nicholas Brook; Camille E Short Journal: Cancers (Basel) Date: 2021-11-25 Impact factor: 6.639
Authors: Alexandre Chan; Kayleen Ports; Patricia Neo; Mothi Babu Ramalingam; Ang Tee Lim; Benedict Tan; Nicolas H Hart; Raymond J Chan; Kiley Loh Journal: Support Care Cancer Date: 2022-02-14 Impact factor: 3.359
Authors: Corinna Meyer-Schwickerath; Maximilian Köppel; Rea Kühl; Janina Bujan Rivera; Angeliki Tsiouris; Gerhard Huber; Joachim Wiskemann Journal: Support Care Cancer Date: 2022-08-29 Impact factor: 3.359
Authors: Anouk E Hiensch; Evelyn M Monninkhof; Martina E Schmidt; Eva M Zopf; Kate A Bolam; Yvonne Wengström; Karen Steindorf; Anne M May; Neil K Aaronson; Jon Belloso; Wilhelm Bloch; Dorothea Clauss; Johanna Depenbusch; Milena Lachowicz; Mireia Pelaez; Helene Rundqvist; Elzbieta Senkus; Martijn M Stuiver; Mark Trevaskis; Ander Urruticoechea; Friederike Rosenberger; Elsken van der Wall; G Ardine de Wit; Philipp Zimmer Journal: Trials Date: 2022-07-29 Impact factor: 2.728